The authors used cell line models, tumor growth studies, and patient samples to assess the role of IKKβ and its activation in cancer.
[Proceedings of the National Academy of Sciences of the United States of America]
Home Newsletters Small-Molecule IKKβ Activation Modulator (IKAM) Targets MAP3K1 and Inhibits Pancreatic Tumor Growth
